
Join to view full profile
450 Brookline AveBoston, MA 02215
Phone+1 617-632-2423
Fax+1 617-632-6570
Dr. Bourgeois is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2018 - 2021
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2018 - 2021
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2014 - 2018
New York University School of MedicineClass of 2014
Certifications & Licensure
MA State Medical License 2018 - 2028
NY State Medical License 2015 - 2018
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 2 citationsCombining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.Nastassja Scheidegger, Constanze Schneider, Gabriela Alexe, Yi-Cheng Wang, Todd A Alonzo
Blood Advances. 2026-07-14 - 2 citationsDegron-independent recruitment of KAT2A expands the target space of CRBN molecular glues.Samuel Ojeda, Meng Wang, Kheewoong Baek, Wallace Bourgeois, Alba Sommerschield
Science. 2026-07-09 - 4 citationsGenetic variation reveals a homeotic long noncoding RNA that modulates human hematopoietic stem cells.Peng Lyu, Gaurav Agarwal, Chun-Jie Guo, Adam Sychla, Wallace Bourgeois
Cell. 2026-06-25
Journal Articles
- Health Care Utilization and Cost Among Pediatric Patients Receiving Unrelated Donor Allogeneic Hematopoietic Cell TransplantationDiane George, Monica Bhatia, Prakash Satwani, James Garvin, Wallace Bourgeois, Nature
Grant Support
- Characterizing and targeting acquired resistance to menin-KMT2A inhibitors in acute myeloid leukemia.DANA-FARBER CANCER INST2026–2031
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: